Post-Detox Thalamic Healing Protocol Tracker

Designed exclusively for structural nerve remodeling, myelination support, and deep-core brain energy optimization.

Pre-Protocol Clinical Clearance Gates

Do not initiate any subsequent phases until both biological clearance milestones are checked off.

GATE 1

October 20th Hair Tissue Mineral Analysis (HTMA) comes back showing low, acceptable arsenic tissue levels.

GATE 2

Follow-Up 24-Hour Urine Test confirms baseline heavy metal excretion has stabilized and active mobilization has ceased completely.

Phase 1: The Stabilized Rebuild (Weeks 1–2 Post-Detox Verification)

Goal: Maintain proven mitochondrial baseline, use ozone to shift the oxygen delivery curve to deep brain vascular beds, and introduce structural fats to physically repair myelin.

05:30 AM

Distilled Water + Comprehensive Trace Mineral Salt, Probiotics, Acetyl-L-Carnitine (ALCAR), Oral PEA 600 mg

06:00 AM

Black Coffee, Selenium, L-Theanine, Taurine, Glycine

07:50 AM

Ozone Therapy Session - Promotes immediate oxygen delivery to the deep brain vascular beds via the Bohr effect and triggers Nrf2 internal antioxidant enzyme shields.

08:00 AM

Oatmeal + Ghee/Coconut Oil, Zinc

12:00 PM

Whole Food Meal, CoQ10, D3/K2/E, Turmeric, Milk Thistle, Oral PEA 600 mg + High-DHA Omega-3 Fatty Acids (Provides the physical structural building blocks for myelin sheath repair)

02:45 PM

Red Light Therapy (810 nm) for 10–15 minutes (Deep cranial mitochondrial penetration to power local repair enzymes)

06:00 PM

Whole Food Meal, Calcium Citrate, Oral PEA 600 mg, Magnesium L-Threonate, Magnesium Glycinate

BEDTIME

L-Serine, 1/2 L-Arginine dissolved in water, Cannabinoid Microdose

Phase 2: Advanced Dual-Route Peptide Integration (Weeks 3–4)

Goal: Utilize systemic BPC-157 for vascular repair from the "outside-in" while sending low-molecular-weight GHK-Cu nasally to trigger direct thalamic myelin synthesis and Nerve Growth Factor (NGF).

*Maintain all baseline elements from Phase 1 continuously during this phase.

06:30 AM

BPC-157 Subcutaneous Injection (Prescription-dose, e.g., 250 mcg) - Administered at your convenience (food does not alter absorption). Works systemically to support blood vessels and lower baseline tissue inflammation.

03:00 PM

GHK-Cu Intranasal Spray (First Micro-Spray) - Aimed at a slight angle outward toward the outer corner of the eye/top of the ear. Small 402 g/mol size allows direct diffusion into cerebrospinal fluid toward deep brain targets. Use a gentle, shallow sniff.

03:15 PM

GHK-Cu Intranasal Spray (Second Micro-Spray) - Administered after waiting 15 minutes to maximize mucosal absorption capacity and prevent liquid overflow into the throat.

Phase 3: The Mitochondrial Acceleration Stack (Week 5+)

Goal: Introduce micro-dosed Methylene Blue to bypass old arsenic mitochondrial locks, creating a maximum energy synergy with your pre-existing 02:45 PM Red Light session.

*Initiate only after demonstrating 4 weeks of complete neurological and sleep stability in the previous phases.

11:00 AM

Methylene Blue (micro-dose) – e.g., 0.5–4 mg, oral or as prescribed. Bypasses mitochondrial electron transport chain bottlenecks; synergizes with red light therapy. Monitor for MAOI-like effects.

⚠️ Protocol Execution & Safety Safeguards

The 7-Day Isolation Rule: When transitioning between phases, do not alter diet, sleep, or other habits. Track any sudden changes in internal vibrations, tremors, or sleep architecture instantly.
The Monoamine Safety Break: Because Methylene Blue acts as a mild MAOI, any emergence of internal tension, racing pulse, or sudden autonomic hyperactivity dictates immediate removal of the compound from your stack.
Regulatory Disclaimer: This tracker reflects an experimental protocol layout. Consult with your prescribing compounding physician to finalize all specific dosages and clinical health monitoring requirements.